Right ventricular enlargement in a patient with hereditary haemorrhagic telangiectasia: a rare case of pulmonary arteriovenous malformations with concomitant atrial septal defect.

of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2010;12:30. 37. Teraoka K, Hirano M, Ookubo H, Sasaki K, Katsuyama H, Amino M et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 2004;22:155–61. 38. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342: 365–73. 39. de Bakker JM, van Capelle FJ, Janse MJ, Tasseron S, Vermeulen JT, de Jonge N et al. Slow conduction in the infarcted human heart: zigzag course of activation. Circulation 1993;88:915–26. 40. Aryana A, d’Avila A, Heist EK, Mela T, Singh JP, Ruskin JN et al. Remote magnetic navigation to guide endocardial and epicardial catheter mapping of scar-related ventricular tachycardia. Circulation 2007;115:1191–200. 41. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the endstage phase of hypertrophic cardiomyopathy. Circulation 2006;114:216–25. 42. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287: 1308–20.